protocolo - Colegio de Medicina Interna de México AC | CMIM

33.Smith SC, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, GrundySM, Hiratzka L, Jones D, Krumholz HM, Mosca L, Pasternak RC,Pearson T, Pfeffer MA, Taubert KA. AHA/ACC Guidelines for secondaryprevention for patients with coronary and other atherosclerotic vasculardisease: 2006 Update. Circulation 2006; 113:2363­2372.34. Snow V, Aronson MD, Hombake ER, Mottur­Pilson C, Weiss KB, for theClinical Efficacy Assessment Subcommittee of the American College ofPhysicians. Ann Intern Med 2004; 140:644­649.35.Costa J, Borges M, David C, Carneiro AV. Efficacy of lipid lowering drugtreatment for diabetic and non­diabetic patients: meta­analysis ofrandomised controlled trials. BMJ 2006; 332: 1115­1124.36.Hu FB. The role of diet and lifestyle modifications in the statin era. J AmDiet Assoc 2005; 105:1718­1721.37.Kirk JK, Passmore LV, Bell RA, Narayan KMV, D’Agostino RB, ArcuryTA, Quandt SA. Disparities in A1c levels between Hispanic and non­Hispanic white adults with diabetes. A meta­analysis. Diabetes Care2008; 31:240­246.17